Filed: 8/7/2023ACC: 0000950123-23-006774
📋 What this filing means
OUP MANAGEMENT CO., LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $58.63M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$58.63M
Total AUM (reported)
11.36M
Total Shares
Allocation by class
COMMON STOCK$40.45M69.0%
SPONSORED ADS$18.18M31.0%
Portfolio Concentration
Top 3$41.01M69.9%
4–10$17.21M29.4%
11–25$417.8K0.7%
Top 3 weight
69.9%
Top 10 weight
99.3%
Voting Authority Distribution
Total shares with voting rights: 11.36M
Sole
Full voting authority
11.36M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
Centessa Pharmaceuticals plc
SOLEShares2.94M
TypeSH
Market value$18.18M
31.01%
Sole
2.94M
Shared
0.00
None
0.00
DICE Therapeutics Inc.
SOLEShares268.35K
TypeSH
Market value$12.47M
21.26%
Sole
268.35K
Shared
0.00
None
0.00
Aerovate Therapeutics Inc.
SOLEShares603.76K
TypeSH
Market value$10.35M
17.66%
Sole
603.76K
Shared
0.00
None
0.00
Cyteir Therapeutics, Inc.
SOLEShares2.46M
TypeSH
Market value$6.39M
10.91%
Sole
2.46M
Shared
0.00
None
0.00
PMV Pharmaceuticals, Inc.
SOLEShares989.23K
TypeSH
Market value$6.19M
10.56%
Sole
989.23K
Shared
0.00
None
0.00
Vor Biopharma Inc.
SOLEShares374.71K
TypeSH
Market value$1.16M
1.97%
Sole
374.71K
Shared
0.00
None
0.00
Graphite Bio
SOLEShares406.31K
TypeSH
Market value$1.06M
1.80%
Sole
406.31K
Shared
0.00
None
0.00
Selecta Biosciences, Inc.
SOLEShares862.54K
TypeSH
Market value$966.0K
1.65%
Sole
862.54K
Shared
0.00
None
0.00
eFFECTOR Therapeutics, Inc.
SOLEShares1.03M
TypeSH
Market value$851.5K
1.45%
Sole
1.03M
Shared
0.00
None
0.00
Precision BioSciences, Inc.
SOLEShares1.12M
TypeSH
Market value$591.2K
1.01%
Sole
1.12M
Shared
0.00
None
0.00
Spero Therapeutics, Inc.
SOLEShares249.07K
TypeSH
Market value$361.2K
0.62%
Sole
249.07K
Shared
0.00
None
0.00
Homology Medicines, Inc.
SOLEShares64K
TypeSH
Market value$56.6K
0.10%
Sole
64K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Centessa Pharmaceuticals plcSOLE | Sponsored ADS | 2.94M | SH | $18.18M 31.01% | 2.94M | 0.00 | 0.00 |
DICE Therapeutics Inc.SOLE | Common Stock | 268.35K | SH | $12.47M 21.26% | 268.35K | 0.00 | 0.00 |
Aerovate Therapeutics Inc.SOLE | Common Stock | 603.76K | SH | $10.35M 17.66% | 603.76K | 0.00 | 0.00 |
Cyteir Therapeutics, Inc.SOLE | Common Stock | 2.46M | SH | $6.39M 10.91% | 2.46M | 0.00 | 0.00 |
PMV Pharmaceuticals, Inc.SOLE | Common Stock | 989.23K | SH | $6.19M 10.56% | 989.23K | 0.00 | 0.00 |
Vor Biopharma Inc.SOLE | Common Stock | 374.71K | SH | $1.16M 1.97% | 374.71K | 0.00 | 0.00 |
Graphite BioSOLE | Common Stock | 406.31K | SH | $1.06M 1.80% | 406.31K | 0.00 | 0.00 |
Selecta Biosciences, Inc.SOLE | Common Stock | 862.54K | SH | $966.0K 1.65% | 862.54K | 0.00 | 0.00 |
eFFECTOR Therapeutics, Inc.SOLE | Common Stock | 1.03M | SH | $851.5K 1.45% | 1.03M | 0.00 | 0.00 |
Precision BioSciences, Inc.SOLE | Common Stock | 1.12M | SH | $591.2K 1.01% | 1.12M | 0.00 | 0.00 |
Spero Therapeutics, Inc.SOLE | Common Stock | 249.07K | SH | $361.2K 0.62% | 249.07K | 0.00 | 0.00 |
Homology Medicines, Inc.SOLE | Common Stock | 64K | SH | $56.6K 0.10% | 64K | 0.00 | 0.00 |